Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/13/2012WO2012122340A1 Soluble guanylate cyclase activators
09/13/2012WO2012122338A1 Process for the preparation of 1,2,4-oxadiazol-3-yl derivatives of carboxylic acid
09/13/2012WO2012122282A1 Low cell toxicity antibiotic hygromycin b
09/13/2012WO2012122279A1 Solid dispersion formulations and methods of use thereof
09/13/2012WO2012122274A1 Self-emulsifying formulations and methods of use thereof
09/13/2012WO2012122264A1 Oxaspiro [2.5] octane derivatives and analogs
09/13/2012WO2012122239A1 MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (miR-155) LINKS INFLAMMATION AND CANCER
09/13/2012WO2012122193A1 Methods and compositions for treating depression using cyclobenzaprine
09/13/2012WO2012122165A2 Substituted n-aryl pyridinones
09/13/2012WO2012122144A1 Highly monodisperse branched peg-lipid conjugates
09/13/2012WO2012122106A2 Compositions and methods apc, creb, and bad pathways to assess and affect cancer
09/13/2012WO2012122077A1 Primary amine diazeniumdiolate heterocyclic derivatives
09/13/2012WO2012122075A1 Lactam derivatives as dgat-1 inhibitors
09/13/2012WO2012122058A2 Alkyne substituted quinazoline compound and methods of use
09/13/2012WO2012122028A2 Pyrazinoisoquinoline compounds
09/13/2012WO2012122011A2 Amino-quinolines as kinase inhibitors
09/13/2012WO2012121992A1 Mst1 kinase inhibitors and methods of their use
09/13/2012WO2012121988A2 Methods for treating diseases using isoindoline compounds
09/13/2012WO2012121957A1 Combination
09/13/2012WO2012121939A2 Aminopyrazine compounds
09/13/2012WO2012121919A2 Selective ligands for the dopamine 3 (d3) receptor and methods of using the same
09/13/2012WO2012121863A1 (--)- huperzine a processes and related compositions and methods of treatment
09/13/2012WO2012121798A2 Thiol-containing compounds for the removal of elements from tissues and formulations therefor
09/13/2012WO2012121764A1 Novel salts and polymorphic forms of afatinib
09/13/2012WO2012121758A1 Melt-extruded solid dispersions containing an apoptosis-inducing agent
09/13/2012WO2012121701A1 Process for the resolution of racemic (±)-10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide
09/13/2012WO2012121662A1 Novel pharmaceutical combinations and methods for treating cancer
09/13/2012WO2012121617A1 Oligosaccharide compounds
09/13/2012WO2012121596A1 Use of vanadium compounds for maintaining normaglycemia in a mammal
09/13/2012WO2012121523A2 Process for preparing pharmaceutical formulation in form of antioxidant-free solution for injection containing pemetrexed or its salt
09/13/2012WO2012121469A1 Antibacterial or preserving composition containing 3-butoxy-1,2-propanediol
09/13/2012WO2012121424A1 Novel oxazolidinone derivative having cyclic amidrazone group and pharmaceutical composition containing same
09/13/2012WO2012121361A1 Dispiropyrrolidine derivative
09/13/2012WO2012121314A1 Dipyridylamine derivative
09/13/2012WO2012121297A1 METHOD FOR PRODUCING 2-O-α-D-GLUCOSYL-L-ASCORBIC ACID ANHYDROUS CRYSTAL-CONTAINING POWDER
09/13/2012WO2012121178A1 Tumor angiogenesis inhibitor
09/13/2012WO2012121168A1 Kinase inhibitor
09/13/2012WO2012121140A1 Growth hormone secretion promoter
09/13/2012WO2012121095A1 Enteral nutrient
09/13/2012WO2012121080A1 Metabolic syndrome ameliorating agent
09/13/2012WO2012121079A1 Compound and method for producing same, as well as method for producing oseltamivir phosphate
09/13/2012WO2012120541A2 Amorphous form of lopinavir and ritonavir mixture
09/13/2012WO2012120522A1 A taste masked chewable tablet of sildenafil
09/13/2012WO2012120476A1 Substituted morpholines as modulators for the calcium sensing receptor
09/13/2012WO2012120469A1 Fluorophenyl bicyclic heteroaryl compounds
09/13/2012WO2012120428A1 Novel kinase inhibitors
09/13/2012WO2012120423A1 Pharmaceutical composition for the prevention or treatment of cancers
09/13/2012WO2012120415A1 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
09/13/2012WO2012120397A1 Fluoro-pyridinone derivatives useful as antibacterial agents
09/13/2012WO2012120365A1 Stable pharmaceutical composition comprising ethinyl estradiol
09/13/2012WO2012120338A1 Method for the preparaton of a levothyroxine solution
09/13/2012WO2012120337A1 Aqueous paracetamol compositions and method of preparation
09/13/2012WO2012120328A1 Formulation comprising phenylaminopyrimidine derivative as active agent
09/13/2012WO2012120284A1 Use of glycopyrrolate for treating tachycardia
09/13/2012WO2012120269A1 Molecular targets for healing or treating wounds
09/13/2012WO2012120262A1 Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
09/13/2012WO2012120236A1 Nutraceutical composition for limiting the absorption of dietary lipids and for inducing weight loss, comprising, as active agent, at least one extract of carrot
09/13/2012WO2012120206A1 Novel dihydro-oxazolobenzodiazepinone derivatives, preparation method thereof and pharmaceutical compositions containing same
09/13/2012WO2012120195A1 New pyridazinone and pyridone compounds
09/13/2012WO2012120099A2 Small molecule modulators of the cold and menthol receptor trpm8
09/13/2012WO2012120082A1 Adenosine and derivatives thereof for use in pain therapy
09/13/2012WO2012120058A1 Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
09/13/2012WO2012120057A1 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
09/13/2012WO2012120056A1 Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
09/13/2012WO2012120055A1 Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/13/2012WO2012120054A1 Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/13/2012WO2012120053A1 Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/13/2012WO2012120052A1 Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
09/13/2012WO2012120051A1 Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
09/13/2012WO2012120050A1 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
09/13/2012WO2012120048A1 Tfeb phosphorylation inhibitors and uses thereof
09/13/2012WO2012120040A1 Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
09/13/2012WO2012120036A1 Orthomolecular agent for countering the consequences of alcohol consumption
09/13/2012WO2012120027A1 Enema compositions
09/13/2012WO2012120023A1 3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
09/13/2012WO2012119997A1 Pharmaceutical formulation for producing rapidly disintegrating tablets
09/13/2012WO2012119980A1 Particles containing a growth factor, and uses thereof
09/13/2012WO2012119979A1 1H-PYROLLO[3,2-d]PYRIMIDINEDIONE DERIVATIVES
09/13/2012WO2012119978A1 Quinolinone derivatives
09/13/2012WO2012119949A1 Means and methods for the treatment of neurodegenerative disorders
09/13/2012WO2012119941A1 Peptidyl nitrilcompounds as peptidase inhibitors
09/13/2012WO2012119938A2 Use of aptamers in therapy and/or diagnosis of autoimmune diseases
09/13/2012WO2012119883A1 1,4 thiazepines/sulfones as bace1 and/or bace2 inhibitors
09/13/2012WO2012119870A1 Oleyl phosphocholine for the treatment of mycosis
09/13/2012WO2012119846A1 Synthetic lta mimetics and use thereof as vaccine component for therapy and/or pro-phylaxis against gram-positive infections
09/13/2012WO2012119841A1 Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid
09/13/2012WO2012119780A2 Novel lipids and novel phospholipids structures
09/13/2012WO2012119729A1 Semisolid aqueous pharmaceutical composition containing tapentadol
09/13/2012WO2012119728A1 Parenteral administration of tapentadol
09/13/2012WO2012119727A1 Aqueous pharmaceutical formulation of tapentadol for oral administration
09/13/2012WO2012119699A1 Alcoholic extract of fungi of genus cunninghamella and use thereof
09/13/2012WO2012119690A1 Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses
09/13/2012WO2012119605A1 New disperse dye with potent anticancer activity
09/13/2012WO2012119559A1 Androgen receptor antagonists and uses thereof
09/13/2012WO2012119550A1 C-glucosidase derivative having cyclopropane structure, preparing method therefor, pharmaceutical composition, and use thereof
09/13/2012WO2012119506A1 Indolone derivatives, pharmaceutical compositions thereof, and preparation methods and applications thereof
09/13/2012WO2012119458A1 Synthesis and use of antitumor drug lqc-y
09/13/2012WO2012119366A1 Β-lactam compound antibiotic composition
09/13/2012WO2012119265A1 NOVEL ESTERS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR DISEASE THERAPIES
09/13/2012WO2012119261A1 Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
1 ... 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 ... 7860